Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1971 2
1973 1
1974 4
1975 2
1977 2
1978 1
1980 2
1981 1
1982 2
1985 1
1986 1
1987 2
1988 3
1989 2
1990 2
1991 7
1992 8
1993 3
1994 4
1995 3
1996 8
1997 6
1998 7
1999 6
2000 4
2001 4
2002 6
2003 7
2004 2
2005 5
2006 10
2007 2
2008 10
2009 13
2010 15
2011 17
2012 12
2013 11
2014 12
2015 8
2016 10
2017 7
2018 7
2019 11
2020 8
2021 10
2022 10
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

258 results
Results by year
Filters applied: . Clear all
Page 1
From Biology to Therapy: The CLL Success Story.
Yosifov DY, Wolf C, Stilgenbauer S, Mertens D. Yosifov DY, et al. Among authors: mertens d. Hemasphere. 2019 Feb 9;3(2):e175. doi: 10.1097/HS9.0000000000000175. eCollection 2019 Apr. Hemasphere. 2019. PMID: 31723816 Free PMC article. Review.
Discovery of Candidate DNA Methylation Cancer Driver Genes.
Pan H, Renaud L, Chaligne R, Bloehdorn J, Tausch E, Mertens D, Fink AM, Fischer K, Zhang C, Betel D, Gnirke A, Imielinski M, Moreaux J, Hallek M, Meissner A, Stilgenbauer S, Wu CJ, Elemento O, Landau DA. Pan H, et al. Among authors: mertens d. Cancer Discov. 2021 Sep;11(9):2266-2281. doi: 10.1158/2159-8290.CD-20-1334. Epub 2021 May 10. Cancer Discov. 2021. PMID: 33972312 Free PMC article. Clinical Trial.
Mutations driving CLL and their evolution in progression and relapse.
Landau DA, Tausch E, Taylor-Weiner AN, Stewart C, Reiter JG, Bahlo J, Kluth S, Bozic I, Lawrence M, Böttcher S, Carter SL, Cibulskis K, Mertens D, Sougnez CL, Rosenberg M, Hess JM, Edelmann J, Kless S, Kneba M, Ritgen M, Fink A, Fischer K, Gabriel S, Lander ES, Nowak MA, Döhner H, Hallek M, Neuberg D, Getz G, Stilgenbauer S, Wu CJ. Landau DA, et al. Among authors: mertens d. Nature. 2015 Oct 22;526(7574):525-30. doi: 10.1038/nature15395. Epub 2015 Oct 14. Nature. 2015. PMID: 26466571 Free PMC article.
Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax.
Tausch E, Schneider C, Robrecht S, Zhang C, Dolnik A, Bloehdorn J, Bahlo J, Al-Sawaf O, Ritgen M, Fink AM, Eichhorst B, Kreuzer KA, Tandon M, Humphrey K, Jiang Y, Schary W, Bullinger L, Mertens D, Lurà MP, Kneba M, Döhner H, Fischer K, Hallek M, Stilgenbauer S. Tausch E, et al. Among authors: mertens d. Blood. 2020 Jun 25;135(26):2402-2412. doi: 10.1182/blood.2019004492. Blood. 2020. PMID: 32206772 Free article.
Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia.
Bloehdorn J, Braun A, Taylor-Weiner A, Jebaraj BMC, Robrecht S, Krzykalla J, Pan H, Giza A, Akylzhanova G, Holzmann K, Scheffold A, Johnston HE, Yeh RF, Klymenko T, Tausch E, Eichhorst B, Bullinger L, Fischer K, Weisser M, Robak T, Schneider C, Gribben J, Dahal LN, Carter MJ, Elemento O, Landau DA, Neuberg DS, Cragg MS, Benner A, Hallek M, Wu CJ, Döhner H, Stilgenbauer S, Mertens D. Bloehdorn J, et al. Among authors: mertens d. Nat Commun. 2021 Sep 13;12(1):5395. doi: 10.1038/s41467-021-25403-y. Nat Commun. 2021. PMID: 34518531 Free PMC article.
Weight and cost of unused operating room supplies.
Poirrier AL, Mertens D, Herman D, Camby S, Scholtes B, Scholtes F. Poirrier AL, et al. Among authors: mertens d. Am J Surg. 2022 Oct;224(4):1174-1175. doi: 10.1016/j.amjsurg.2022.05.030. Epub 2022 May 25. Am J Surg. 2022. PMID: 35637017 No abstract available.
Outpatient burn management.
Mertens DM, Jenkins ME, Warden GD. Mertens DM, et al. Nurs Clin North Am. 1997 Jun;32(2):343-64. Nurs Clin North Am. 1997. PMID: 9115481 Review.
Triggering T-cell activity in CLL.
Mertens D, Krönke J. Mertens D, et al. Blood. 2021 Jan 14;137(2):150-151. doi: 10.1182/blood.2020009360. Blood. 2021. PMID: 33443561 Free article. No abstract available.
Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial.
Ehlken N, Lichtblau M, Klose H, Weidenhammer J, Fischer C, Nechwatal R, Uiker S, Halank M, Olsson K, Seeger W, Gall H, Rosenkranz S, Wilkens H, Mertens D, Seyfarth HJ, Opitz C, Ulrich S, Egenlauf B, Grünig E. Ehlken N, et al. Among authors: mertens d. Eur Heart J. 2016 Jan 1;37(1):35-44. doi: 10.1093/eurheartj/ehv337. Epub 2015 Jul 31. Eur Heart J. 2016. PMID: 26231884 Free PMC article. Clinical Trial.
Predictability of Biotic Stress Structures Plant Defence Evolution.
Mertens D, Boege K, Kessler A, Koricheva J, Thaler JS, Whiteman NK, Poelman EH. Mertens D, et al. Trends Ecol Evol. 2021 May;36(5):444-456. doi: 10.1016/j.tree.2020.12.009. Epub 2021 Jan 16. Trends Ecol Evol. 2021. PMID: 33468354 Free PMC article. Review.
258 results